MeSH D014946 - wound infection
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cloxacillin | Cloxacillin | 1982-01-01 | |||
| Oxacillin | Oxacillin | 1982-01-01 | ||||
| Novast Laboratories | Mafenide | Mafenide | 2017-07-31 | |||
| Mylan | Mafenide | Sulfamylon | 1998-06-05 | |||
| GSK | Oxacillin | Bactocill | 1982-01-01 | |||
| Cloxacillin | Cloxapen | 1982-01-01 | ||||
| Nafcillin | Nallpen | 1982-01-01 | ||||
| Sandoz | Nafcillin | Nafcillin | 1984-08-02 | |||
| Oxacillin | Oxacillin | 1982-01-01 | ||||
| Wyeth | Nafcillin | Unipen | 1986-12-16 | |||
| King Pharmaceuticals | Silver sulfadiazine | Silvadene | 1982-01-01 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
44%4/9
Phase 2
69%11/16
Phase 3
57%17/30
Approved: 6Overall Success rate: 17%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use